This report contains market size and forecasts of Atezolizumab in global, including the following market information:
Global Atezolizumab Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Atezolizumab Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Atezolizumab companies in 2021 (%)
The global Atezolizumab market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Use: Single Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Atezolizumab include Genentech (Roche). etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Atezolizumab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Atezolizumab Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Atezolizumab Market Segment Percentages, by Type, 2021 (%)
Use: Single Drug
Use: Chemotherapy Combination
Global Atezolizumab Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Atezolizumab Market Segment Percentages, by Application, 2021 (%)
Bladder Cancer
Lung Cancer
Advanced Triple-negative Breast Cancer
Head and Neck Cancer
Urothelial Carcinoma
Renal Cell Carcinoma
Hepatocellular Carcinoma (HCC)
Other
Global Atezolizumab Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Atezolizumab Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Atezolizumab revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Atezolizumab revenues share in global market, 2021 (%)
Key companies Atezolizumab sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Atezolizumab sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Genentech (Roche)